Annabel can take her meds and enjoy her life 

Annabel Murphy (aged 8) who has cystic fibrosis with Prof. Paul McNally, RCSI Associate Professor of Paediatrics at the launch of a new €3m study, led by RCSI, to investigate the real-world effects of a new cystic fibrosis medication.

New cystic fibrosis medication means the future is much brighter for children such as Annabel Murphy.

Annabel was tested for CF as part of the newborn bloodspot programme that was introduced here in 2011.